CORONA acquires Obimet, Thyrocab brands from Abbott India; to launch manufacturing unit in Gujarat CORONA Remedies acquires two brands Obimet and Thyrocab, comprising of 14 product line extensions, from Abbott India. With Value addition to CORONA’s portfolio, these brands are popular prescription drugs to manage diabetes and hyperthyroidism. Both brands are expected to garner approximate sales […]
